Understanding people’s perspectives regarding birth control is critical for ensuring that the development of the next generation of contraception is rooted in users’ wants and needs.
Male Contraceptive Initiative (MCI) is dedicated to bringing safe, non-hormonal, and reversible birth control options to men. We prioritize user needs by actively researching what people want in a contraceptive. By funding market research and utilizing external insights, we ensure the development of methods that are not only effective but also desirable for long-term use. On this page, you'll find details about MCI's market research activities, along with resources that demonstrate the clear demand for male contraception solutions.
MCI-supported Market Research
MCI's International Market Research Report
To understand the global need for male contraception, Male Contraceptive Initiative funded a comprehensive international market research study. This study explored men's interest in and preferences for new birth control methods, as well as female partners' trust in men using contraception. The study's findings can be found on this microsite.
To understand the global need for male contraception, Male Contraceptive Initiative funded a comprehensive international market research study. This study explored men's interest in and preferences for new birth control methods, as well as female partners' trust in men using contraception. The study's findings can be found on this microsite.
MCI’s Domestic Consumer Research Report
Male Contraceptive Initiative (MCI) spearheaded a groundbreaking study to understand men's experiences with current birth control options. This research looked across different demographics to identify unmet needs and satisfaction levels. The report you'll find here dives into the study's findings, revealing valuable insights about what men truly want from the future of contraception.
Male Contraceptive Initiative (MCI) spearheaded a groundbreaking study to understand men's experiences with current birth control options. This research looked across different demographics to identify unmet needs and satisfaction levels. The report you'll find here dives into the study's findings, revealing valuable insights about what men truly want from the future of contraception.
External Market Research Efforts
Nguyen BT. The Demand for Male Contraception: estimating the potential market for users of novel male contraceptive methods using United States National Survey of Family Growth data. Contraception. 2024 Mar 28:110438. doi: 10.1016/j.contraception.2024.110438. Epub ahead of print. PMID: 38555051.
Glasier A. Acceptability of contraception for men: a review. Contraception. 2010 Nov;82(5):453-6. doi: 10.1016/j.contraception.2010.03.016. Epub 2010 May 4. PMID: 20933119.
Eberhardt J, van Wersch A, Meikle N. Attitudes towards the male contraceptive pill in men and women in casual and stable sexual relationships. J Fam Plann Reprod Health Care. 2009 Jul;35(3):161-5. doi: 10.1783/147118909788707986. PMID: 19622206.
Vouking MZ, Evina CD, Tadenfok CN. Male involvement in family planning decision making in sub-Saharan Africa- what the evidence suggests. Pan Afr Med J. 2014 Dec 3;19:349. doi: 10.11604/pamj.2014.19.349.5090. PMID: 25922638; PMCID: PMC4406389.
Roth MY, Shih G, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Sitruk-Ware R, Blithe DL, Amory JK. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial. Contraception. 2014 Oct;90(4):407-12. doi: 10.1016/j.contraception.2014.05.013. Epub 2014 Jun 2. PMID: 24981149; PMCID: PMC4269220.
Ramos-Ortiz J, King H, DeMaria AL. Hormonal Male Contraception: Formative Research to Develop and Test Communication Messaging. Am J Mens Health. 2022 May-Jun;16(3):15579883221094702. doi: 10.1177/15579883221094702. PMID: 35748372; PMCID: PMC9240595.
Glasier A. Acceptability of contraception for men: a review. Contraception. 2010 Nov;82(5):453-6. doi: 10.1016/j.contraception.2010.03.016. Epub 2010 May 4. PMID: 20933119.
Eberhardt J, van Wersch A, Meikle N. Attitudes towards the male contraceptive pill in men and women in casual and stable sexual relationships. J Fam Plann Reprod Health Care. 2009 Jul;35(3):161-5. doi: 10.1783/147118909788707986. PMID: 19622206.
Vouking MZ, Evina CD, Tadenfok CN. Male involvement in family planning decision making in sub-Saharan Africa- what the evidence suggests. Pan Afr Med J. 2014 Dec 3;19:349. doi: 10.11604/pamj.2014.19.349.5090. PMID: 25922638; PMCID: PMC4406389.
Roth MY, Shih G, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Sitruk-Ware R, Blithe DL, Amory JK. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial. Contraception. 2014 Oct;90(4):407-12. doi: 10.1016/j.contraception.2014.05.013. Epub 2014 Jun 2. PMID: 24981149; PMCID: PMC4269220.
Ramos-Ortiz J, King H, DeMaria AL. Hormonal Male Contraception: Formative Research to Develop and Test Communication Messaging. Am J Mens Health. 2022 May-Jun;16(3):15579883221094702. doi: 10.1177/15579883221094702. PMID: 35748372; PMCID: PMC9240595.
